Search Results - "Ruggiero, Angelo"

Author reply to: Comment on: 'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?'.

Authors: Ruggiero, Angelo Megna, Matteo Caiazzo, Giuseppina et al.

Source: Clinical & Experimental Dermatology. Apr2023, Vol. 48 Issue 4, p396-397. 2p.

Fortgeschrittenes Plattenepithelkarzinom, das sich auf einer chronischen Hidradenitis suppurativa entwickelt hat und erfolgreich mit Cemiplimab behandelt wurde: ein Fallbericht.

Authors: Ruggiero, Angelo Lauro, Wanda Miano, Chiara et al.

Source: Kompass Dermatologie. 2025, Vol. 13 Issue 1, p49-52. 4p.

Efficacy and safety of bimekizumab in real-world psoriasis management: data from patients who are biologic-naive vs. biologic-experienced.

Authors: Megna, Matteo Ruggiero, Angelo Torta, Ginevra et al.

Source: Clinical & Experimental Dermatology. Oct2024, Vol. 49 Issue 10, p1186-1189. 4p.

Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report.

Authors: Ruggiero, Angelo Lauro, Wanda Miano, Chiara et al.

Source: Case Reports in Dermatology. 2023, Vol. 15 Issue 1, p35-39. 5p.

Tildrakizumab for the treatment of moderate to severe psoriasis: Results from a single center preliminary real‐life study.

Authors: Ruggiero, Angelo Potestio, Luca Cacciapuoti, Sara et al.

Source: Dermatologic Therapy. Dec2022, Vol. 35 Issue 12, p1-4. 4p.

A case of esophageal candidiasis in a psoriatic patient treated with ixekizumab: Should treatment be discontinued?

Authors: Ruggiero, Angelo Megna, Matteo Marino, Vincenzo et al.

Source: Dermatologic Therapy. Apr2022, Vol. 35 Issue 4, p1-3. 3p.

Cutaneous Squamous Cell Carcinoma: From Diagnosis to Follow-Up.

Authors: Comune, Rosita Ruggiero, Angelo Portarapillo, Antonio et al.

Source: Cancers. Sep2024, Vol. 16 Issue 17, p2960. 15p.

The impact of COVID‐19 infection on patients with psoriasis treated with biologics: an Italian experience.

Authors: Ruggiero, Angelo Martora, Fabrizio Picone, Vincenzo et al.

Source: Clinical & Experimental Dermatology. Dec2022, Vol. 47 Issue 12, p2280-2282. 3p. 1 Color Photograph, 1 Chart.

A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab.

Authors: Ruggiero, Angelo Lauro, Wanda Fabbrocini, Gabriella et al.

Source: Case Reports in Dermatology. 2022, Vol. 14 Issue 2, p138-143. 6p.

Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study.

Authors: Megna, Matteo Ruggiero, Angelo Battista, Teresa et al.

Source: Journal of Clinical Medicine. May2023, Vol. 12 Issue 9, p3233. 10p.

Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study.

Authors: Megna, Matteo Ruggiero, Angelo Martora, Fabrizio et al.

Source: Journal of Clinical Medicine. May2024, Vol. 13 Issue 9, p2691. 9p.

Dupilumab-associated inflammatory arthritis: a literature review.

Authors: Napolitano, Maddalena Ruggiero, Angelo Patruno, Cataldo

Source: Clinical & Experimental Dermatology. Apr2024, Vol. 49 Issue 4, p307-312. 6p.

Comment on 'Associations between hidradenitis suppurativa and dermatological conditions in adults: a national cross-sectional study'.

Authors: Martora, Fabrizio Ruggiero, Angelo Battista, Teresa et al.

Source: Clinical & Experimental Dermatology. Aug2023, Vol. 48 Issue 8, p938-939. 2p.

A unilateral slow-growing yellow nodule of the glans penis.

Authors: Ruggiero, Angelo Marasca, Claudio Fabbrocini, Gabriella et al.

Source: Clinical & Experimental Dermatology. Jan2023, Vol. 48 Issue 1, p48-50. 3p. 3 Color Photographs.

Comment on 'Oral ivermectin to treat scabies: a comparison of two different regimens'.

Authors: Potestio, Luca Ruggiero, Angelo Fabbrocini, Gabriella et al.

Source: Clinical & Experimental Dermatology. Jun2023, Vol. 48 Issue 6, p695-696. 2p.

Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa.

Authors: Megna, Matteo Ruggiero, Angelo Di Guida, Adriana et al.

Source: Dermatologic Therapy. Jul/Aug2020, Vol. 33 Issue 4, p1-4. 4p.

Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?

Authors: Ruggiero, Angelo Marasca, Claudio Fabbrocini, Gabriella et al.

Source: Journal of Cosmetic Dermatology. Feb2023, Vol. 22 Issue 2, p677-678. 2p.

Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti‐interleukin‐17 treatment: A real‐life 52‐week retrospective study.

Authors: Ruggiero, Angelo Fabbrocini, Gabriella Cinelli, Eleonora et al.

Source: Dermatologic Therapy. Jan/Feb2021, Vol. 34 Issue 1, p1-6. 6p.

Patient satisfaction with remote dermatology consultations during the COVID‐19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID‐19 pandemic in a single, secondary‐care dermatology department'

Authors: Martora, Fabrizio Ruggiero, Angelo Fabbrocini, Gabriella et al.

Source: Clinical & Experimental Dermatology. Nov2022, Vol. 47 Issue 11, p2037-2038. 2p.

The impact of COVID‐19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre.

Authors: Ruggiero, Angelo Martora, Fabrizio Fornaro, Luigi et al.

Source: Clinical & Experimental Dermatology. Nov2022, Vol. 47 Issue 11, p2024-2025. 2p. 1 Chart.